Negara: Singapura
Bahasa: Inggris
Sumber: HSA (Health Sciences Authority)
TELMISARTAN
BOEHRINGER INGELHEIM SINGAPORE PTE. LTD.
C09CA07
80 mg
TABLET
TELMISARTAN 80 mg
ORAL
Prescription Only
BOEHRINGER INGELHEIM PHARMA GMBH & CO KG
ACTIVE
1999-08-16
1 Abcd PACKAGE LEAFLET: INFORMATION FOR THE USER MICARDIS 40MG TABLETS MICARDIS 80MG TABLETS Telmisartan READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What MICARDIS is and what it is used for 2. What you need to know before you take MICARDIS 3. How to take MICARDIS 4. Possible side effects 5. How to store MICARDIS 6. Contents of the pack and other information 7. Marketing Authorization Holder and Manufacturer 8. Product registration number 9. Date of revision 1. WHAT MICARDIS IS AND WHAT IT IS USED FOR MICARDIS is used to treat essential hypertension (high blood pressure) in adults. MICARDIS contains telmisartan belongs to a class of medicines called angiotensin II receptor antagonists. Angiotensin-II is a substance produced in your body which causes your blood vessels to narrow thus increasing your blood pressure. Telmisartan blocks the effect of angiotensin II so that the blood vessels relax, and your blood pressure is lowered. High blood pressure, if not treated, can damage blood vessels in several organs, which could lead sometimes to heart attack, heart or kidney failure, stroke, or blindness. There are usually no symptoms of high blood pressure before damage occurs. Thus it is important to regularly measure blood pressure to verify if it is within the normal range. MICARDIS is also used to reduce cardiovascular events (i.e. heart attack or stroke) in adults 55 years or older who are at risk because they have a reduced or blocked blood supply to the heart or legs, or have had a stroke Baca dokumen lengkapnya
1 MICARDIS ® Abcd 1. NAME OF THE MEDICINAL PRODUCT Micardis 40 mg tablets Micardis 80 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Micardis 40 mg tablets Each tablet contains 40 mg telmisartan Micardis 80 mg tablets Each tablet contains 80 mg telmisartan For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Tablet Micardis 40 mg tablets 40mg: White or off white, oblong tablets; one face marked with 51H, the other face with the Boehringer Ingelheim company symbol Micardis 80mg tablets 80mg: White or off white, oblong tablets; one face marked with “52H”, the other face with the Boehringer Ingelheim company symbol 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of essential hypertension in adults. Reduction of the risk of non-fatal stroke or non-fatal myocardial infarction in adults 55 years or older at high risk of developing major cardiovascular events who cannot tolerate an angiotensin coverting enzyme inhibitor (ACEI). High risk of cardiovascular events includes evidence of coronary artery disease, peripheral arterial disease, stroke, transient ischemic attack, or diabetes mellitus with evidence of end-organ damage. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY TREATMENT OF ESSENTIAL HYPERTENSION The recommended dose is 40 mg once daily. Some patients may already benefit at a daily dose of 20 mg. In cases where the target blood pressure is not achieved, telmisartan dose can be increased to a maximum of 80 mg once daily. When considering raising the dose, it must be borne in mind that the maximum antihypertensive effect is generally attained four to eight weeks after the start of treatment. Alternatively, telmisartan may be used in combination with thiazide-type diuretics such as hydrochlorothiazide or calcium- channel-blockers such as amlodipine, which have been shown to have an additive blood pressure lowering effect with telmisartan. In patients with severe hypertension treatment with telmisartan at doses up to 160 mg alone and in combination with hydrochloro Baca dokumen lengkapnya